高级搜索
人神经母细胞瘤SK-H-SN细胞株的多药耐药性及逆转研究[J]. 肿瘤防治研究, 1997, 24(1): 10-12.
引用本文: 人神经母细胞瘤SK-H-SN细胞株的多药耐药性及逆转研究[J]. 肿瘤防治研究, 1997, 24(1): 10-12.
Multidrug Resistance and Reversion study on Human Neuroblastoma SK-H-SN Cell Line[J]. Cancer Research on Prevention and Treatment, 1997, 24(1): 10-12.
Citation: Multidrug Resistance and Reversion study on Human Neuroblastoma SK-H-SN Cell Line[J]. Cancer Research on Prevention and Treatment, 1997, 24(1): 10-12.

人神经母细胞瘤SK-H-SN细胞株的多药耐药性及逆转研究

Multidrug Resistance and Reversion study on Human Neuroblastoma SK-H-SN Cell Line

  • 摘要: 本文对人神经母细胞瘤SK-H-SN细胞株的多药耐药性及其逆转进行实验,LSAB免疫组织化学定位显示整个SK-H-SN细胞膜表面以及细胞质内都有较强的耐药性P-170糖蛋白;MTT细胞毒性分析法证实,分别合用维拉帕米和双嘧啶胺醇前后,SK-H-SN细胞株细胞对抗肿瘤药物阿霉素、长春新碱的敏感性均有显著性差异(P<0.01)。表明维拉帕米和双嘧啶胺醇对人神经母细胞瘤SK-H-SN细胞株的耐药性有逆转作用。

     

    Abstract: Experiment was done on human neuroblastoma SK-H-SN cell line about its multidrug resistance and reversion. with ABC immunohistoehemical localization, both the cytoplasma and cell membrane showed abundant P-glycoprotein staining,MTT cytotoxic assay revealed that the sensitivities of SK-H-SN cells to doxoruieine or vincristine were significantly different according to the presence or absence of ve-rapamil or dipyridamole(P<0.0 1), which indicate that the drug resistance of SK-H-SN cells can be reversed by verapamil or dipyridamole.

     

/

返回文章
返回